Inhibrx
INBX
$34.30
Share price
0.44%
Change (1 day)
29.68%
Change (1 year)
Categories
Inhibrx (INBX) - Cash on Hand
Cash on Hand as of December 2023 : $0.27 B
According to Inhibrx's latest financial reports the company has $0.27 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Inhibrx - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.27 B | 1.48% |
| 2022-12-31 | $0.27 B | 108.58% |
| 2021-12-31 | $0.13 B | 2.05% |
| 2020-12-31 | $0.12 B | 1014.94% |
| 2019-12-31 | $11.54 M | 448.74% |
| 2018-12-31 | $2.1 M | -84.39% |
| 2017-12-31 | $13.47 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -25.09% | 🇺🇸 USA |